(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Live Chart Being Loaded With Signals
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients...
Stats | |
---|---|
今日成交量 | 27 400.00 |
平均成交量 | 40 470.00 |
市值 | 1.24M |
EPS | $-0.0700 ( 2024-02-23 ) |
下一个收益日期 | ( $-0.110 ) 2024-07-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.110 |
ATR14 | $0.00200 (4.65%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-05 | Ghadar-ghadr Arash | Buy | 100 000 | Common Stock |
2022-01-05 | Ghadar-ghadr Arash | Buy | 0 | |
2022-01-28 | Natha Salim | Buy | 8 000 | Stock Option (right to buy) |
2022-01-28 | Moore Thomas Peter | Buy | 8 000 | Stock Option (right to buy) |
2022-01-31 | Mclarney Justin James | Buy | 22 293 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 26 transactions |
Buy: 137 623 617 | Sell: 137 373 875 |
Nemaura Medical Inc 财务报表
Annual | 2023 |
营收: | $77 044.00 |
毛利润: | $-1.48M (-1 916.30 %) |
EPS: | $-1.010 |
FY | 2023 |
营收: | $77 044.00 |
毛利润: | $-1.48M (-1 916.30 %) |
EPS: | $-1.010 |
FY | 2022 |
营收: | $503 906 |
毛利润: | $159 606 (31.67 %) |
EPS: | $-0.590 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.280 |
Financial Reports:
No articles found.
Nemaura Medical Inc
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。